arrow
P

Piotr Czauderna

fahrenheit universities
H指数:40
被引数:7,893

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Updated ERNICA guidelines for the management of rectosigmoid Hirschsprung's disease 2025

2025年直肠乙状结肠型先天性巨结肠病管理更新版ER-NICA指南

2026-07-012
OAAI
Evacuating Patients With Pediatric Cancer From Ukraine: Impact on Medical Care Capacity in Poland
2025-02-010
OAAI
Upfront or delayed surgery in resectable hepatoblastoma: analysis from the children's hepatic tumors international collaboration database
2024-10-010
OAAI
Identification of IGF2 as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma
2023-02-106
OA
Impact of COVID-19 pandemic on paediatric surgical training across Europe
2022-09-124
OA
Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications
2020-08-0183
OAAI
Microscopically positive resection margin after hepatoblastoma resection: what is the impact on prognosis? A Childhood Liver Tumours Strategy Group (SIOPEL) report

肝母细胞瘤切除术后显微镜下阳性切缘: 对预后有什么影响?儿童肝肿瘤策略小组 (SIOPEL) 报告

2019-01-0147
PREAI
The (C)under-barhildren's (H)under-barepatic tumors (I)under-barnternational (C)under-barollaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model
2016-01-01196
OAAI
Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma - Results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience
2013-08-0180
OA
Cultural Bias in the AAP's 2012 Technical Report and Policy Statement on Male Circumcision

AAP关于男性包皮环切术的2012技术报告和政策声明中的文化偏见

2013-04-01102
OAAI
Efficacy of irinotecan single drug treatment in children with refractory or recurrent hepatoblastoma - A phase II trial of the childhood liver tumour strategy group (SIOPEL)
2012-12-0148
PREAI